VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 159 filers reported holding VIKING THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,815 | +28.7% | 289,240 | -27.3% | 0.00% | 0.0% |
| Q4 2022 | $3,742 | -94.6% | 398,093 | +1456.0% | 0.00% | – |
| Q3 2022 | $69,000 | +43.8% | 25,585 | +58.6% | 0.00% | – |
| Q1 2022 | $48,000 | -65.5% | 16,133 | -46.9% | 0.00% | – |
| Q4 2021 | $139,000 | +531.8% | 30,400 | +533.5% | 0.00% | – |
| Q1 2020 | $22,000 | -65.1% | 4,799 | -39.8% | 0.00% | – |
| Q4 2019 | $63,000 | -86.4% | 7,968 | -88.2% | 0.00% | -100.0% |
| Q3 2019 | $463,000 | +382.3% | 67,411 | +481.5% | 0.00% | – |
| Q2 2019 | $96,000 | +33.3% | 11,593 | +21.6% | 0.00% | – |
| Q4 2018 | $72,000 | -93.4% | 9,534 | -84.7% | 0.00% | -100.0% |
| Q3 2018 | $1,086,000 | +670.2% | 62,358 | +317.0% | 0.00% | +200.0% |
| Q2 2018 | $141,000 | +314.7% | 14,954 | +91.8% | 0.00% | 0.0% |
| Q1 2018 | $34,000 | – | 7,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |